Pregnancy Prediction Using Anti-Müllerian Hormone in Intrauterine Insemination Cycles

Completed

• Conditions: Infertility, Female; Anti-Mullerian Hormone Deficiency
• Interventions: Procedure: Intrauterine insemination

• Registration Number: NCT06263192
• Lead Sponsor: Jose Antonio Moreno

Brief Summary

The goal of this study is to compare the cumulative pregnancy rates after 4 artificial inseminations with donor (IAD) in non-sterile women with plasma AMH levels \> and \< 1.1 ng/mL.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-10-01
• Primary Completion: 2022-12-01
• Study Completion: 2023-05-01
• Study First Submitted: 2023-05-11
• Status Verified: 2024-02
• Study First Submitted QC: 2024-02-08
• Last Update Submitted: 2024-02-08
• Study First Posted: 2024-02-16
• Last Update Posted: 2024-02-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 342

Inclusion Criteria

• IUI cycles with sperm donors either due to severe oligoasthenoteratozoospermia in the partner (defined as a motile sperm count (MSC) < 5 million in the ejaculate) or for social reasons, with up to 4 attempts accounted for.

Exclusion Criteria

• BMI >30
• Infertility due to bilateral tubal factor
• Endometriosis grade II-IV.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
AMH > 1.1 ng/ml	Intrauterine insemination	-
AMH < 1.1 ng/ml	Intrauterine insemination	-

Primary Outcome Measures

Name	Time	Method
Cummulative pregnancy rate	36 months	Pregnancy rate after 4 cycles of IUI

Trial Locations

Locations (1)

Fertty International; 🇪🇸 Barcelona, Spain